Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00519987
Status:
COMPLETED
Last Update Posted:
2008-01-10
First Post:
2007-08-21
Brief Title:
Multiple Dose Pharmacokinetics of Intranasal Ketamine
Sponsor:
Javelin Pharmaceuticals
Organization:
Javelin Pharmaceuticals
Study Overview
Official Title:
An Open Label Single Center Study to Assess the Pharmacokinetics Safety and Tolerability of Multiple Administrations of 30 mg PMI-150 Intranasal Ketamine in Healthy Adult Volunteers
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open label single-center study of the pharmacokinetic and safety profile of repeat doses of PMI-150 intranasal ketamine 30 mg in healthy adult volunteers
Detailed Description:
To examine safety and characterize the repeat dosing plasma profile effect on absorption and accumulation following repeated administration of 30 mg doses of PMI-150 intranasal ketamine to healthy adult volunteers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None